PubMed Health⌕ Search

PubMed · 1945549

Infantile colic. Is it a gut issue?

Abstract

Despite its salience in terms of both prevalence and distress occasioned in parents, the nature and causes of infantile colic remain poorly understood. Causes in the gut (abnormal sensitivity to dietary components, excessive gas, intestinal hypermotility, hormonal factors) and alternative explanations (variant of normal crying behavior, effect of atypical parenting, manifestation of problems in parent-infant interaction) are critically reviewed. Gut pathology may, at best, explain a minority of cases. Although evidence in support of both sets of causes exists, it is frequently undermined by methodologic limitations, notably inadequate definition of the subjects studied. Conceptual issues have also constrained progress in resolving some of the dilemmas, specifically the assumption that gut and non-gut causes are mutually exclusive, and that presence of symptoms necessarily implies abnormalities of function. It is proposed that (1) colic may not be a homogeneous group, but a loose description for the crying of various clinical and etiological subgroups; and (2) that most cases may be conceptualized as resulting from behavioral and biologic interactions in which both the behavioral and biologic factors are functioning normally rather than pathologically.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A R Miller, R G Barr. 1991. Infantile colic. Is it a gut issue?. https://doi.org/10.1016/s0031-3955(16)38227-x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Reduction of crying episodes owing to infantile colic: A randomized controlled study on the efficacy of a new infant formula.

OBJECTIVES: The aim of this study was to evaluate the efficacy on crying episodes owing to infantile colic of a new infant formula containing partially hydrolysed whey proteins, prebiotic oligosaccharides (OS), with a high beta-palmitic acid content. DESIGN: Prospective randomized controlled study. SETTING: Italy. SUBJECTS: Two hundred and sixty-seven formula-fed infants, aged less than 4 months, with infantile colic, were randomized to receive either the new infant formula (study treatment (ST)) or a standard formula and simethicone (6 mg/kg twice a day) (control treatment (CT)). A questionnaire was given to parents to evaluate for 14 days the daily number of colic episodes and crying time. RESULTS: Out of the 199 infants who completed the study, 96 were treated with the new formula and 103 were not treated. Infants receiving the new formula had a significant decrease in colic episodes after 1 week (2.47+/-1.94 at day 7 vs 5.99+/-1.84 at the study entry) compared to infants receiving the CT (3.72+/-1.98 at day 7 vs 5.41+/-1.88 at the study entry) (P < 0.0001). Also at day 14, the crying episodes were significantly different between the two groups of infants (1.76+/-1.60 in ST vs 3.32+/-2.06 in CT) (P < 0.0001). CONCLUSIONS: The use of a partially hydrolysed formula supplemented with fructo- and galacto-OS induces a reduction of crying episodes in infants with colic after 7 and 14 days when compared with a standard formula and simethicone.

Colic↗